The natural history of childhood-onset nonallergic rhinitis; a long-term follow-up study.

IF 1.9 4区 医学 Q3 ALLERGY
Kantima Kanchanapoomi, Witchaya Srisuwatchari, Punchama Pacharn, Nualanong Visitsunthorn, Orathai Jirapongsananuruk
{"title":"The natural history of childhood-onset nonallergic rhinitis; a long-term follow-up study.","authors":"Kantima Kanchanapoomi, Witchaya Srisuwatchari, Punchama Pacharn, Nualanong Visitsunthorn, Orathai Jirapongsananuruk","doi":"10.12932/AP-140922-1455","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Non-allergic rhinitis (NAR) is characterized by symptoms of nasal inflammation without allergic sensitization. The long-term outcome of NAR in children is poorly defined.</p><p><strong>Objective: </strong>To determine the natural history of childhood-onset NAR and the development of allergic rhinitis (AR) in these children.</p><p><strong>Methods: </strong>NAR patients who were followed for more than 10 years were evaluated at 3-5 years (E2) and 9-12 years (E3) after the first evaluation (E1). Nasal symptoms, disease severity, comorbidities, medication used, and aeroallergen sensitization were assessed.</p><p><strong>Results: </strong>Eighty-two NAR patients (58.5% male) completed all 3 evaluations. The age at onset was 2.0 (range 2.0-4.0) years. The follow-up period was 13.6 (range 12.3-14.3) years. At E2, 37.8% of patients developed AR. At E3, the patients were classified into four groups based on results of skin prick tests in E2 and E3 (group I: NAR→NAR→NAR, 39.0%, group II: NAR→NAR→AR, 23.2%, group III: NAR→AR→NAR, 12.2% and group IV: NAR→AR→AR, 25.6%). The most common aeroallergen sensitization was house dust mite. The family history of atopy, asthma and allergic rhinitis were higher in group III and IV than other groups (p < 0.05). The atopic dermatitis, obstructive sleep apnea and adenotonsillar hypertrophy at E1 and E2 were predominantly found in group IV (p < 0.05). At E2, group III and IV patients had higher proportion of exposure to house dust, animal dander and smoking compared to other groups (p < 0.05). The overall remission rate was 14.6%.</p><p><strong>Conclusions: </strong>Children with NAR should be reevaluated periodically to determine aeroallergen sensitization for the appropriate diagnosis and management.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":"168-177"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific journal of allergy and immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12932/AP-140922-1455","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Non-allergic rhinitis (NAR) is characterized by symptoms of nasal inflammation without allergic sensitization. The long-term outcome of NAR in children is poorly defined.

Objective: To determine the natural history of childhood-onset NAR and the development of allergic rhinitis (AR) in these children.

Methods: NAR patients who were followed for more than 10 years were evaluated at 3-5 years (E2) and 9-12 years (E3) after the first evaluation (E1). Nasal symptoms, disease severity, comorbidities, medication used, and aeroallergen sensitization were assessed.

Results: Eighty-two NAR patients (58.5% male) completed all 3 evaluations. The age at onset was 2.0 (range 2.0-4.0) years. The follow-up period was 13.6 (range 12.3-14.3) years. At E2, 37.8% of patients developed AR. At E3, the patients were classified into four groups based on results of skin prick tests in E2 and E3 (group I: NAR→NAR→NAR, 39.0%, group II: NAR→NAR→AR, 23.2%, group III: NAR→AR→NAR, 12.2% and group IV: NAR→AR→AR, 25.6%). The most common aeroallergen sensitization was house dust mite. The family history of atopy, asthma and allergic rhinitis were higher in group III and IV than other groups (p < 0.05). The atopic dermatitis, obstructive sleep apnea and adenotonsillar hypertrophy at E1 and E2 were predominantly found in group IV (p < 0.05). At E2, group III and IV patients had higher proportion of exposure to house dust, animal dander and smoking compared to other groups (p < 0.05). The overall remission rate was 14.6%.

Conclusions: Children with NAR should be reevaluated periodically to determine aeroallergen sensitization for the appropriate diagnosis and management.

儿童期非过敏性鼻炎的自然发病史;一项长期随访研究。
背景:非变应性鼻炎(Non-allergic rhinitis, NAR)以无过敏性致敏的鼻部炎症症状为特征。儿童NAR的长期预后尚不明确。目的:了解儿童NAR的自然发病史及变应性鼻炎(AR)的发展情况。方法:随访10年以上的NAR患者在第一次评估(E1)后3-5年(E2)和9-12年(E3)进行评估。评估鼻腔症状、疾病严重程度、合并症、使用的药物和气致过敏原致敏性。结果:82例NAR患者(58.5%)完成了所有3项评估。发病年龄2.0岁(范围2.0 ~ 4.0岁)。随访时间为13.6年(12.3-14.3年)。E2时,37.8%的患者发生AR。E3时,根据E2和E3时皮肤点刺试验结果将患者分为4组(I组:NAR→NAR→NAR, 39.0%, II组:NAR→NAR→AR, 23.2%, III组:NAR→AR→NAR, 12.2%, IV组:NAR→AR→AR, 25.6%)。最常见的空气过敏原致敏是屋尘螨。III、IV组患者特应性、哮喘、变应性鼻炎家族史高于其他组(p < 0.05)。IV组以异位性皮炎、阻塞性睡眠呼吸暂停、E1、E2腺扁桃体肥大为主(p < 0.05)。E2时,与其他组相比,III组和IV组患者对室内灰尘、动物皮屑和吸烟的暴露比例更高(p < 0.05)。总缓解率为14.6%。结论:NAR患儿应定期重新评估,以确定空气过敏原的致敏性,以便进行适当的诊断和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
12.80
自引率
0.00%
发文量
74
审稿时长
>12 weeks
期刊介绍: The Asian Pacific Journal of Allergy and Immunology (APJAI) is an online open access journal with the recent impact factor (2018) 1.747 APJAI published 4 times per annum (March, June, September, December). Four issues constitute one volume. APJAI publishes original research articles of basic science, clinical science and reviews on various aspects of allergy and immunology. This journal is an official journal of and published by the Allergy, Asthma and Immunology Association, Thailand. The scopes include mechanism, pathogenesis, host-pathogen interaction, host-environment interaction, allergic diseases, immune-mediated diseases, epidemiology, diagnosis, treatment and prevention, immunotherapy, and vaccine. All papers are published in English and are refereed to international standards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信